Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics Versus Placebo for Acute Bacterial Conjunctivitis in Children
2013-005623-16Phase 4Completed
- Sponsor
- Minna Honkila
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in conjunctivitis and bacterial conjunctivitis (BC) comparing Moxifloxacin eye drops with Placebo (Celluvisc carmellose sodium) eye drops (2 arms). Primary endpoint: Time to clinical cure. Started Feb 2014; status: completed.
02
Drugs
moxifloxacin
03
Conditions
conjunctivitisbacterial conjunctivitis (BC)
Beyond the preview
Go deeper on 2013-005623-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005623-16.